MCM2 and hepatocellular carcinoma: Here we propose that the CpG site cg08889930 could represent the methylation status of the MCM2 gene and consequently the expression level of MCM2. Its mehylation level could serve not only as prognostic marker to evaluate HCC patient progression but also as predictive marker to evaluate the efficacy of a therapeutic intervention.